Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.
about
Options for the treatment of febrile catatonia.Special medical conditions associated with catatonia in the internal medicine setting: hyponatremia-inducing psychosis and subsequent catatonia.Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment.Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor bindingClozapine responsive catatonia: A series of five cases.Clinical manifestations, diagnosis, and empirical treatments for catatonia.Adolescent catatonia successfully treated with Lorazepam and aripiprazole.Catatonic syndrome associated with lead intoxication: a case reportClozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?Catatonic schizophrenia and the use of memantine.Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia.Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy.Systematic review of catatonia treatment.Neuropsychodynamic Approach to Depression: Integrating Resting State Dysfunctions of the Brain and Disturbed Self-Related Processes.
P2860
Q33953456-B08EDFBF-75AC-4888-9BD5-582C00646847Q33975739-068D8863-1CA4-421D-9CC5-EB9FCD3E0EEDQ35183261-D3C51E75-F7FA-4D6B-B0FD-07C1883B9CF0Q35453044-D437CE56-05AE-4092-A628-9B8A86EAB786Q36917649-576A697F-EF45-45C8-B115-8263D944BE6AQ37784139-E0BBDF96-51B2-4A35-93F1-BF262295A486Q38245740-D9E64C66-5202-427D-8671-17DFEE99D686Q41959027-25250AE7-92EF-45B0-A4CB-7B77D459343CQ46570370-D8A95EC4-C0E1-4A91-837A-AF41A12F8FA3Q46870122-00B044BF-EF15-4D65-A288-919D97BF81C7Q48181141-B6747B3E-6CEE-4A0C-A5ED-B7CDB7CB4F96Q48909230-0A48243C-86EA-4E2E-9EF0-39F24D2FF0A7Q49337312-387391AD-A759-48A4-9E7E-0B40E13B6C18Q55666472-4EEEB874-DE76-4FAB-BDFF-9CAB34D4F1E1
P2860
Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@en
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@nl
type
label
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@en
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@nl
prefLabel
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@en
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@nl
P2093
P2860
P356
P1476
Glutamatergic dysfunction in c ...... he NMDA antagonist amantadine.
@en
P2093
P2860
P304
P356
10.1136/JNNP.62.4.404
P407
P577
1997-04-01T00:00:00Z